Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections — IGNITE4

Complicated Appendicitis Clinical Trial

Official title:
A Phase 3, Randomized, Double-Blind, Double-Dummy, Multicenter, Prospective Study to Assess the Efficacy and Safety of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections

Status Completed

Clinical Trial Summary

This is a Phase 3, randomized, double-blind, double-dummy, multicenter, prospective study to assess the efficacy, safety, and pharmacokinetics (PK) of eravacycline compared with meropenem in the treatment of complicated intra-abdominal infections (cIAIs).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02784704
Study type	Interventional
Source	La Jolla Pharmaceutical Company
Contact
Status	Completed
Phase	Phase 3
Start date	October 13, 2016
Completion date	May 19, 2017

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06102239` - New Diagnostic Markers In Dignosis Of Complicated Appendix	N/A
Recruiting	`NCT04803422` - Per Oral Versus Intravenous Postoperative Antibiotics After Surgery for Complicated Appendicitis.	N/A
Terminated	`NCT03795194` - Antibiotic Duration in Post-appendectomy Abscess	Phase 4
Completed	`NCT05375058` - Complicated Appendicitis During the COVID-19 Pandemic in Jordan
Completed	`NCT03159754` - Optimal Care of Complicated Appendicitis	Phase 4
Completed	`NCT01678365` - Safety and Efficacy of Single Daily Dose of Ceftriaxone and Metronidazole for Treatment of Complicated Appendicitis in Children	Phase 4
Completed	`NCT05470517` - Antibiotic Instillation in Appendicitis	Phase 2
Completed	`NCT03712657` - ERAS for Pediatric Acute Appendicitis	N/A
Completed	`NCT05012839` - Complicated Appendicitis in COVID-19 Era
Completed	`NCT05005104` - Causes of Complicated Appendicitis at Referral Hospital
Recruiting	`NCT05761080` - Fast Track Therapeutic Model in Acute Complicated Appendicitis in Pediatrics	Phase 4